Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
346 participants
INTERVENTIONAL
2010-02-28
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary purposes are to assess the feasibility and desirability of a post-emergency medical consultation for adolescents who scored high on a self-administered questionnaire, and to assess the impact of this approach by later monitoring.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated Prevention and Collaborative Care for Youth Mental Health
NCT03114007
Using a Digital Application for Adolescents in Dropout of Care in Mental Health : Facilitate the Return in Classic Care With Telepsychiatry, Tchats, Forums and a Home Medical Team.
NCT06088576
Prevention of Depression in At-Risk Adolescents
NCT00073671
Psychiatry of Transition in a World in Transition
NCT04333797
Efficacity of Psychological Intervention on Reducing the Suicidal Ideations, Depression Level and Improving Reinsertion
NCT03655730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The project is as follows:
Phase A :
\- Evaluation of the prevalence: systematic execution of self-administered questionnaire by all adolescents consulting, night and day in each center.
Phase B :
* For adolescents whose outcome questionnaire exceed 4, a post-emergency consultation will be proposed within 15 days.
* Telephone survey, 12 months after the passage of emergency every teenager who completed self-administered questionnaire and presenting himself to the post-emergency consultation. This survey will aim to assess the psychological status of adolescents and the impact of any specific treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
screening of adolescent mental suffering. Management
screening of adolescent mental suffering consultant to emergencies. Management and later monitoring
consultation 10 days later
new depression screening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
consultation 10 days later
new depression screening
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
13 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Fondation de France
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chantal Stheneur, MD
Role: PRINCIPAL_INVESTIGATOR
Ambroise Paré University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of paediatric emergencies, Ambroise Paré universitary hospital
Boulogne-Billancourt, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P090103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.